+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Regenerative Medicine for Cartilage Global Market Report 2021: COVID-19 Growth and Change

  • ID: 5306546
  • Report
  • March 2021
  • Region: Global
  • 200 pages
  • The Business Research Company

FEATURED COMPANIES

  • Arthrex Inc.
  • B. Braun Melsungen AG
  • BioTissue Technologies
  • CellGenix
  • Collagen Solutions PLC
  • CONMED Corporation
Regenerative Medicine For Cartilage Global Market Report 2021: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global regenerative medicine for cartilage market.

This report focuses on regenerative medicine for cartilage market which is experiencing strong growth. The report gives a guide to the regenerative medicine for cartilage market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the regenerative medicine for cartilage? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Regenerative Medicine For Cartilage market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider regenerative medicine for cartilage market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The regenerative medicine for cartilage market section of the report gives context. It compares the regenerative medicine for cartilage market with other segments of the regenerative medicine for cartilage market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, regenerative medicine for cartilage indicators comparison.
Scope

Markets Covered:
1) By Treatment Modality: Cell-Based; Non-Cell-Based
2) By Treatment Type: Palliative; Intrinsic Repair Stimulus; Others
3) By Site: Knee Cartilage Repair; Ribs; Others
4) By Application: Hyaline Cartilage Repair and Regeneration; Elastic Cartilage Repair and Regeneration; Fibrous Cartilage Repair and Regeneration
5) By End-Use: Ambulatory Surgical Centers; Hospitals & Clinics; Surgical Centers; Others

Companies Mentioned: B. Braun Melsungen AG; Zimmer Biomet Holdings Inc.; Vericel Corporation; Stryker Corporation; Smith & Nephew plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arthrex Inc.
  • B. Braun Melsungen AG
  • BioTissue Technologies
  • CellGenix
  • Collagen Solutions PLC
  • CONMED Corporation
1. Executive Summary

2. Regenerative Medicine for Cartilage Market Characteristics

3. Regenerative Medicine for Cartilage Market Trends and Strategies

4. Impact of COVID-19 on Regenerative Medicine for Cartilage

5. Regenerative Medicine for Cartilage Market Size and Growth
5.1. Global Regenerative Medicine for Cartilage Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on the Market
5.2. Global Regenerative Medicine for Cartilage Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market

6. Regenerative Medicine for Cartilage Market Segmentation
6.1. Global Regenerative Medicine for Cartilage Market, Segmentation by Treatment Modality, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Cell-Based
  • Non-Cell-Based
6.2. Global Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Palliative
  • Intrinsic Repair Stimulus
  • Others
6.3. Global Regenerative Medicine for Cartilage Market, Segmentation by Site, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Knee Cartilage Repair
  • Ribs
  • Others
6.4. Global Regenerative Medicine for Cartilage Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hyaline Cartilage Repair and Regeneration
  • Elastic Cartilage Repair and Regeneration
  • Fibrous Cartilage Repair and Regeneration
6.5. Global Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Ambulatory Surgical Centers
  • Hospitals & Clinics
  • Surgical Centers
  • Others
7. Regenerative Medicine for Cartilage Market Regional and Country Analysis
7.1. Global Regenerative Medicine for Cartilage Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Regenerative Medicine for Cartilage Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Regenerative Medicine for Cartilage Market
8.1. Asia-Pacific Regenerative Medicine for Cartilage Market Overview
  • Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Regenerative Medicine for Cartilage Market
9.1. China Regenerative Medicine for Cartilage Market Overview
9.2. China Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Regenerative Medicine for Cartilage Market
10.1. India Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Regenerative Medicine for Cartilage Market
11.1. Japan Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Regenerative Medicine for Cartilage Market
12.1. Australia Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Regenerative Medicine for Cartilage Market
13.1. Indonesia Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Regenerative Medicine for Cartilage Market
14.1. South Korea Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Regenerative Medicine for Cartilage Market
15.1. Western Europe Regenerative Medicine for Cartilage Market Overview
15.2. Western Europe Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Regenerative Medicine for Cartilage Market
16.1. UK Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Regenerative Medicine for Cartilage Market
17.1. Germany Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Regenerative Medicine for Cartilage Market
18.4. France Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Regenerative Medicine for Cartilage Market
19.1. Eastern Europe Regenerative Medicine for Cartilage Market Overview
19.2. Eastern Europe Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Regenerative Medicine for Cartilage Market
20.1. Russia Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Regenerative Medicine for Cartilage Market
21.1. North America Regenerative Medicine for Cartilage Market Overview
21.2. North America Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Regenerative Medicine for Cartilage Market
22.1. USA Regenerative Medicine for Cartilage Market Overview
22.2. USA Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Regenerative Medicine for Cartilage Market
23.1. South America Regenerative Medicine for Cartilage Market Overview
23.2. South America Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Regenerative Medicine for Cartilage Market
24.1. Brazil Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Regenerative Medicine for Cartilage Market
25.1. Middle East Regenerative Medicine for Cartilage Market Overview
25.2. Middle East Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Regenerative Medicine for Cartilage Market
26.1. Africa Regenerative Medicine for Cartilage Market Overview
26.2. Africa Regenerative Medicine for Cartilage Market, Segmentation by Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Regenerative Medicine for Cartilage Market, Segmentation by End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Regenerative Medicine for Cartilage Market Competitive Landscape and Company Profiles
27.1. Regenerative Medicine for Cartilage Market Competitive Landscape
27.2. Regenerative Medicine for Cartilage Market Company Profiles
27.2.1. B. Braun Melsungen AG
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Zimmer Biomet Holdings Inc.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Vericel Corporation
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Stryker Corporation
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Smith & Nephew plc
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers and Acquisitions in the Regenerative Medicine for Cartilage Market

29. Regenerative Medicine for Cartilage Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arthrex Inc.
  • B. Braun Melsungen AG
  • BioTissue Technologies
  • CellGenix
  • Collagen Solutions PLC
  • CONMED Corporation
Major players in the regenerative medicine for cartilage market are B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC, BioTissue Technologies, CellGenix, Osiris Therapeutics Inc., and DePuy Synthes.

The global regenerative medicine for cartilage market is expected to grow from $4.47 billion in 2020 to $4.83 billion in 2021 at a compound annual growth rate (CAGR) of 8.10%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.56 billion in 2025 at a CAGR of 7.94%.

The regenerative medicine for cartilage market consists of sales of regenerative medicines for the cartilage by entities (organizations, sole traders, and partnerships) that have the capacity to grow muscles and organs in the lab and safely implant them when the body cannot regenerate itself, as observed for cartilage tissue after injury or wear. Only goods and services traded between entities or sold to end consumers are included.

The main types of regenerative medicine for cartilage are cell-based and non-cell-based. The type of treatment includes palliative and intrinsic repair stimulus among others that are used by ambulatory surgical centers, hospitals and clinics, and surgical centers. The regenerative medicine for cartilage is used for hyaline cartilage repair and regeneration, elastic cartilage repair and regeneration, and fibrous cartilage repair and regeneration.

Europe was the largest region in regenerative medicine for cartilage in 2020. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The high cost of regenerative medicine therapies is one of the major factors limiting the growth of the market for regenerative medicine for cartilage. The average cost for knee replacement is around $4,500 to $8,400, while the average cost of cartilage repair procedures is around $18,000, depending on the country where the procedure is being performed. Such high prices discourage individuals to resort to cartilage repair therapies, and in turn, result in a lower preference for these procedures.

In April 2019, Smith & Nephew plc, a UK-based multinational medical equipment manufacturing company, acquired Osiris Therapeutics, Inc. for approximately $660 million. The acquisition is expected to stimulate growth from Smith & Nephew’s advanced wound management franchise. Osiris Therapeutics, Inc. is a US-based company that researches and develops therapeutic products for the regeneration of human connective tissues.

The growing incidence of osteoarthritis across the globe will drive the market for regenerative medicine for cartilage. Osteoarthritis is a degenerative joint disorder that mostly attacks the articular cartilage. According to the Arthritis Foundation in 2019, degenerative joint disease disorders such as osteoarthritis will impact at least 130 million individuals around the globe by 2050. Some of the most commonly used treatments for osteoarthritis are autologous chondrocyte implantation and scaffold implants. Thus, the increasing incidence of osteoarthritis is expected to drive the demand for the market for regenerative medicine for cartilage.

Tissue engineering and stem cell therapy are emerging trends in the regenerative medicine for cartilage market. The growth of tissue engineering technology has given hope for the regeneration of cartilage. Stem cell therapy is gaining attention with its advantages over traditional orthopedic treatments. Stem cell therapy helps to reduce knee pain and improves knee cartilage regeneration and repair. For instance, growth factors in the form of platelet-rich plasma (PRP) therapy are injected to promote tissue regeneration effectively. Companies operating in the market are continuously focusing on introducing new technologies to survive in the regenerative medicine for cartilage market.

The countries covered in the regenerative medicine for cartilage market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Note: Product cover images may vary from those shown
  • B. Braun Melsungen AG
  • Zimmer Biomet Holdings Inc.
  • Vericel Corporation
  • Stryker Corporation
  • Smith & Nephew plc
  • Arthrex Inc.
  • CONMED Corporation
  • Collagen Solutions PLC
  • BioTissue Technologies
  • CellGenix
  • Osiris Therapeutics Inc.
  • DePuy Synthes
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll